Hypertonic Saline 3% Nebulizer versus intravenous hypertonic saline 3% in ARDS
Phase 1
- Conditions
- Respiratory
- Registration Number
- PACTR201909691980023
- Lead Sponsor
- amr sobhy abdelkway
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 104
Inclusion Criteria
both sexes
age of 18-60 years
fulfilling Berlin definition of ARDS as follows:
Exclusion Criteria
Presence of heart failure or evidence of fluid overload
renal failure
hyperventilate patient
refuse to anticipate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method